Published in Contraception on November 01, 1997
Carrageenan is a potent inhibitor of papillomavirus infection. PLoS Pathog (2006) 2.65
Vaginal microbicides: detecting toxicities in vivo that paradoxically increase pathogen transmission. BMC Infect Dis (2006) 2.01
Mucus-penetrating nanoparticles for vaginal drug delivery protect against herpes simplex virus. Sci Transl Med (2012) 1.68
Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonate. Antimicrob Agents Chemother (2001) 1.39
Microbicide excipients can greatly increase susceptibility to genital herpes transmission in the mouse. BMC Infect Dis (2010) 1.09
Comparative in vitro sensitivities of human immune cell lines, vaginal and cervical epithelial cell lines, and primary cells to candidate microbicides nonoxynol 9, C31G, and sodium dodecyl sulfate. Antimicrob Agents Chemother (2002) 1.07
Marine polysaccharides from algae with potential biomedical applications. Mar Drugs (2015) 1.04
IgG in cervicovaginal mucus traps HSV and prevents vaginal herpes infections. Mucosal Immunol (2014) 1.02
Ex vivo characterization of particle transport in mucus secretions coating freshly excised mucosal tissues. Mol Pharm (2013) 0.86
Non-specific microbicide product development: then and now. Curr HIV Res (2012) 0.85
Single and multiple exposure tolerance study of polystyrene sulfonate gel: a phase I safety and colposcopy study. Contraception (2004) 0.85
Nanoparticle-based drug delivery to the vagina: a review. J Control Release (2014) 0.83
Prophylactic treatment with a novel bioadhesive gel formulation containing aciclovir and tenofovir protects from HSV-2 infection. J Antimicrob Chemother (2014) 0.81
Antiviral Potential of Algae Polysaccharides Isolated from Marine Sources: A Review. Biomed Res Int (2015) 0.80
In vivo anti-herpes simplex virus activity of a sulfated derivative of Agaricus brasiliensis mycelial polysaccharide. Antimicrob Agents Chemother (2013) 0.77
Antibody-based concepts for multipurpose prevention technologies. Antiviral Res (2013) 0.76
Pretreatment of human cervicovaginal mucus with pluronic F127 enhances nanoparticle penetration without compromising mucus barrier properties to herpes simplex virus. Biomacromolecules (2014) 0.75
Lateral diffusion of rhodopsin in the photoreceptor membrane. Nature (1974) 11.38
Rotational diffusion of rhodopsin in the visual receptor membrane. Nat New Biol (1972) 6.97
Lateral diffusion of phodopsin in Necturus rods. Exp Eye Res (1973) 4.02
Dark ionic flux and the effects of light in isolated rod outer segments. J Gen Physiol (1972) 3.68
Diffusion of macromolecules and virus-like particles in human cervical mucus. Biophys J (2001) 3.18
Antibody diffusion in human cervical mucus. Biophys J (1994) 2.82
Selection of a fixative for identifying T cell subsets, B cells, and macrophages in paraffin-embedded mouse spleen. J Immunol Methods (1983) 2.82
Acid production by vaginal flora in vitro is consistent with the rate and extent of vaginal acidification. Infect Immun (1999) 2.42
Origins of vaginal acidity: high D/L lactate ratio is consistent with bacteria being the primary source. Hum Reprod (2001) 2.26
Early receptor potential: photoreversible charge displacement in rhodopsin. Science (1967) 2.17
Infection of monocytes during measles. J Infect Dis (1993) 2.14
Basis of neurovirulence in Sindbis virus encephalomyelitis of mice. Lab Invest (1988) 2.05
Preventing disease by protecting the cervix: the unexplored promise of internal vaginal barrier devices. AIDS (2001) 1.75
Tests of Buffergel for contraception and prevention of sexually transmitted diseases in animal models. Sex Transm Dis (2001) 1.72
The pathogenesis of spinal cord involvement in the encephalomyelitis of mice caused by neuroadapted Sindbis virus infection. Lab Invest (1987) 1.63
Lateral diffusion of rhodopsin in photoreceptor cells measured by fluorescence photobleaching and recovery. Biophys J (1981) 1.60
A double labeling technique for performing immunocytochemistry and in situ hybridization in virus infected cell cultures and tissues. J Virol Methods (1985) 1.60
Rhodopsin cycle in the living eye of the rat. Nature (1969) 1.59
Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes. Nat Biotechnol (1996) 1.57
Efficiency of in situ hybridization as a function of probe size and fixation technique. J Virol Methods (1985) 1.47
Septic arthritis caused by Propionibacterium acnes. JAMA (1982) 1.45
Dense fibers protect mammalian sperm against damage. Biol Reprod (1990) 1.36
Light activates rotations of bacteriorhodopsin in the purple membrane. Biophys J (1984) 1.34
Borna disease virus replicates in astrocytes, Schwann cells and ependymal cells in persistently infected rats: location of viral genomic and messenger RNAs by in situ hybridization. J Neuropathol Exp Neurol (1991) 1.30
Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-gamma with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol (1996) 1.30
Macromolecules released from polymers: diffusion into unstirred fluids. Biomaterials (1990) 1.29
Using monoclonal antibodies to prevent mucosal transmission of epidemic infectious diseases. Emerg Infect Dis (1999) 1.29
Membrane characteristics and osmotic behavior of isolated rod outer segments. J Cell Biol (1973) 1.27
Spontaneous regeneration of rhodopsin in the isolated rat retina. Nature (1969) 1.26
Immunocytochemical identification and quantitation of the mononuclear cells in the cerebrospinal fluid, meninges, and brain during acute viral meningoencephalitis. J Exp Med (1984) 1.21
Calcium content of frog rod outer segments and discs. Biochim Biophys Acta (1977) 1.16
A humanized monoclonal antibody produced in transgenic plants for immunoprotection of the vagina against genital herpes. Nat Biotechnol (1998) 1.15
Limulus rhodopsin: rapid return of transient intermediates to the thermally stable state. Science (1973) 1.12
Preventing infectious disease with passive immunization. Microbes Infect (2000) 1.12
Residence half-life of IgG administered topically to the mouse vagina. Biol Reprod (1996) 1.11
The rate at which human sperm are immobilized and killed by mild acidity. Fertil Steril (2000) 1.10
Passive immunization of the vagina protects mice against vaginal transmission of genital herpes infections. J Infect Dis (1994) 1.06
The electric dipole moment of rhodopsin solubilized in Triton X-100. Biophys J (1975) 1.02
Nonoxynol-9 protects mice against vaginal transmission of genital herpes infections. J Infect Dis (1993) 1.00
Ionic blockage of the light-regulated sodium channels in isolated rod outer segments. J Gen Physiol (1978) 1.00
Topically applied human recombinant monoclonal IgG1 antibody and its Fab and F(ab')2 fragments protect mice from vaginal transmission of HSV-2. Virology (1996) 0.97
Controlled vaginal delivery of antibodies in the mouse. Biol Reprod (1992) 0.96
The early receptor potential of the vertebrate eye. Cold Spring Harb Symp Quant Biol (1965) 0.95
Identification of the inflammatory cells in the central nervous system of patients with adrenoleukodystrophy. Ann Neurol (1985) 0.94
Developing multipurpose reproductive health technologies: an integrated strategy. AIDS Res Treat (2013) 0.94
Rat sperm are mechanically immobilized in the caudal epididymis by "immobilin," a high molecular weight glycoprotein. Biol Reprod (1983) 0.93
Epidemiologic observations on feline immunodeficiency virus and Toxoplasma gondii coinfection in cats in Baltimore, Md. J Am Vet Med Assoc (1989) 0.92
Functional independence of the two major components of the rod electroretinogram. Nature (1965) 0.91
Characterization of the local and systemic B cell response of normal and athymic nude mice with Sindbis virus encephalitis. J Neuroimmunol (1989) 0.90
The strength of non-covalent biological bonds and adhesions by multiple independent bonds. J Theor Biol (1990) 0.90
In vitro studies of the role of monocytes in the immunosuppression associated with natural measles virus infections. Clin Immunol Immunopathol (1987) 0.87
Mechanics of sperm-egg interaction at the zona pellucida. Biophys J (1988) 0.86
Brain endothelial cell infection in children with acute fatal measles. J Clin Invest (1995) 0.86
Light-stimulated electrical responses from skin. Science (1966) 0.85
Contraceptive testing of vaginal agents in rabbits. Contraception (1998) 0.85
Peripheral blood mononuclear cells during natural measles virus infection: cell surface phenotypes and evidence for activation. Clin Immunol Immunopathol (1986) 0.85
Lateral diffusion of rhodopsin in the visual receptor membrane. J Supramol Struct (1973) 0.83
Transient dichroism in photoreceptor membranes indicates that stable oligomers of rhodopsin do not form during excitation. Biophys J (1985) 0.83
Polyherbal formulations with wide spectrum antimicrobial activity against reproductive tract infections and sexually transmitted pathogens. Am J Reprod Immunol (2000) 0.83
Monoclonal antibodies for reproductive health: Part I. Preventing sexual transmission of disease and pregnancy with topically applied antibodies. Am J Reprod Immunol (1994) 0.82
Reducing methicillin-resistant Staphylococcus aureus (MRSA) patient exposure by infection control measures. Ann R Coll Surg Engl (2005) 0.81
Antigen-releasing polymer rings and microspheres stimulate mucosal immunity in the vagina. J Control Release (1998) 0.80
Contraceptive effect of sperm-agglutinating monoclonal antibodies in rabbits. Biol Reprod (1997) 0.80
Melanin, a possible pigment for the photostable electrical responses of the eye. Nature (1967) 0.78
Kinetic characterization of the inhibition of purified cynomolgus monkey lactate dehydrogenase isozymes by gossypol. J Androl (1987) 0.78
Immune responses in the central nervous system. Toxicol Pathol (1987) 0.78
Comparison of an anti-HSV-2 monoclonal IgG and its IgA switch variant for topical immunoprotection of the mouse vagina. J Reprod Immunol (1998) 0.77
Mechanical immobilization of rat sperm does not change their oxygen consumption rate. Biol Reprod (1986) 0.77
Transgenic commensals as mucosal protectants. Nat Biotechnol (2000) 0.76